Q1 2024 EPS Estimates for Corcept Therapeutics Incorporated (NASDAQ:CORT) Lifted by Zacks Research

Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) – Stock analysts at Zacks Research upped their Q1 2024 earnings per share (EPS) estimates for Corcept Therapeutics in a research note issued on Tuesday, December 26th. Zacks Research analyst K. Das now anticipates that the biotechnology company will post earnings per share of $0.20 for the quarter, […]

Leave a Reply

Your email address will not be published.

Previous post Kelly McKinney: Are we as a nation ready for the next big threat? What Oct. 7 and the pandemic have taught us
Next post Raia Drogasil S.A. (OTCMKTS:RADLY) Raises Dividend to $0.01 Per Share